Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host diseas...
Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
About this item
Full title
Author / Creator
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Vedolizumab, an immunosuppressive drug that acts locally on the gastrointestinal tract, is mainly used for the treatment of inflammatory bowel disease, and has been reported to be effective against gastrointestinal acute graft-versus-host disease (GI-aGVHD) in adults. However, there is insufficient evidence for pediatric GI-aGVHD. We used vedolizum...
Alternative Titles
Full title
Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2592316148
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2592316148
Other Identifiers
ISSN
0925-5710
E-ISSN
1865-3774
DOI
10.1007/s12185-021-03245-0
